MedPath

Dexmedetomidine (as hydrochloride) in 0.9% Sodium Chloride

Generic Name: Dexmedetomidine (as hydrochloride) in 0.9% Sodium Chloride

Active
Registration Number

DR-XY48779

Dosage Form

Solution for IV Infusion

Issuance Date

June 23, 2023

Expiry Date

June 23, 2028

Product Information

Philippine FDA product specifications and classification details

Product Specifications

Dosage Strength4 mcg/mL
PackagingType I clear glass x 100 mL with rubber stopper and aluminum blue flip-off seal (Box of 10's)

Classification

C
Classification
Prescription Drug (RX)
P
Pharmacologic
Hypnotic and Sedative
A
Application
Monitore Release [MR]
Philippine FDA Classification

Active Ingredients (1)

Complete list of active ingredients in this pharmaceutical product.

Dexmedetomidine (as hydrochloride) in 0.9% Sodium ChlorideActive
Monograph: dexmedetomidine (as hydrochloride) in 0.9% sodium chloride

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

MedPath - Medical Intelligence Platform